Genocure AI is developing AI-powered solutions for oncology drug discovery and development.
About
Genocure AI combines next-generation genomics with powerful AI to guide smarter, personalized cancer treatments. Their advanced precision oncology platform, Supreme™, integrates multi-omic data with AI-driven algorithms to identify optimal therapeutic combinations for individual patients. They serve healthcare providers and the pharmaceutical industry, with future plans to assist patients directly.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
23Traction
0Team
30Visibility
8Profile
45Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Genocure AI do?
Genocure AI combines next-generation genomics with powerful AI to guide smarter, personalized cancer treatments. Their advanced precision oncology platform, Supreme™, integrates multi-omic data with AI-driven algorithms to identify optimal therapeutic combinations for individual patients. They serve healthcare providers and the pharmaceutical industry, with future plans to assist patients directly.
How much funding has Genocure AI raised?
Genocure AI has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Genocure AI headquartered?
Genocure AI is headquartered in San Francisco, United States.
When was Genocure AI founded?
Genocure AI was founded in 2023.
What industry does Genocure AI operate in?
Genocure AI operates in Life Sciences, Oncology, Biotech, Drug Discovery, AI-Driven Drug Discovery, Foundation Model.